Wednesday, Jan 7, 2026 · SEC filings

What the smart money revealed on Jan 7

Real insider buys27insiders · $4.5M
Real insider sales72insiders · $77.6M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

540 insider filings came in. We hid 96 planned (10b5-1) sellers and 318 people whose filings were routine, like grants and tax withholding.

group

5 insiders at Indivior (INDV) bought $172K of stock

Roles: Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jan 5
$172K
group

4 insiders at WaterBridge Infrastructure (WBI) bought $264K of stock

Roles: CEO, Officer. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jan 5–6
$264K
group

3 insiders at LandBridge (LB) bought $165K of stock

Roles: Officer. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jan 5–6
$165K
trending_up

Intellia Therapeutics (NTLA) Director Fred Cohen bought $1.4M

150,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 5
$1.4M
trending_up

Align Alternative Access Fund (ALTIX) Director Jeffrey Leinan bought $980K

96,330 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Nov 3–Dec 1
$980K
trending_up

TriplePoint Venture Growth BDC (TPVG) CEO James Labe bought $493K

74,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 3 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 0 of 3 beat Traded Jan 5–6
$493K
trending_up

Cidara Therapeutics (CDTX) President & CEO Jeffrey Stein bought $339K

Open-market buys of more than one share class. Not a grant or an option exercise.

Real buy Form 4 Traded Mar 31–Nov 10
$339K
trending_down

Redwire (RDW) Director Michael Greene sold $19.4M

Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 83.63M shares.

Real sale Form 4 Traded Jan 6
$19.4M
trending_down

Permian Resources (PR) Co-CEO William Hickey sold $10.6M

Not marked as a planned 10b5-1 sale. Sold 43% of the shares they held directly. Still holds 1.01M shares.

Real sale Form 4 Sold 43% of stake Traded Jan 5–6
$10.6M
trending_down

Netskope (NTSK) CEO and Chairman Sanjay Beri sold $3.61M

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Jan 6–7
$3.61M
Show 11 more real buys
Show 69 more real sales
PR Permian Resources · Co-CEO James Walter · Traded Jan 5–6
$10.6M
CPT Camden Property Trust · Chairman and CEO Richard Campo · Traded Jan 5–6
$4.79M
PR Permian Resources · EVP Guy Oliphint · Traded Jan 5–6
$4.13M
TECTP Tectonic Financial · Director Thomas Sanders · Traded Jan 5
$4.07M
TECTP Tectonic Financial · Director Steven Clapp · Traded Jan 5
$4.07M
PR Permian Resources · EVP Robert Shannon · Traded Jan 5–6
$2.42M
PR Permian Resources · EVP John Bell · Traded Jan 5–6
$2.42M
ACTU Actuate Therapeutics · Director Todd Thomson · Traded Jan 5
$1.62M
PPTA Perpetua Resources · Officer Mckinsey Lyon · Traded Jan 5
$865K
NTSK Netskope · CFO Andrew Del Matto · Traded Jan 6
$856K
PLAB Photronics · Director Kang Lee · Traded Jan 5–6
$693K
CPT Camden Property Trust · President & CFO Alexander Jessett · Traded Jan 5
$617K
AMBA Ambarella · Senior VP Chi-Hong Ju · Traded Jan 5
$584K
MRVL Marvell Technology · EVP & Chief Legal Officer Mark Casper · Traded Jan 5
$465K
PPTA Perpetua Resources · Director Jeffrey Malmen · Traded Jan 5–6
$401K
PLAB Photronics · Director Mary Paladino · Traded Jan 6
$395K
PPTA Perpetua Resources · Director Chris Robison · Traded Jan 5–6
$361K
PPTA Perpetua Resources · Director Alexander Sternhell · Traded Jan 5–7
$356K
RLAY Relay Therapeutics · President and CEO Sanjiv Patel · Traded Jan 6
$338K
FNF Fidelity National Financial · Director Halim Dhanidina · Traded Jan 5
$335K
NTLA Intellia Therapeutics · President and CEO John Leonard · Traded Jan 5
$314K
CPT Camden Property Trust · Director Kelvin Westbrook · Traded Jan 5
$244K
CPT Camden Property Trust · Director Heather Brunner · Traded Jan 5
$231K
PLAB Photronics · Director Mitchell Tyson · Traded Jan 6
$176K
FUND Sprott Focus Trust · Director W George · Traded Jan 6
$157K
RUN Sunrun · CEO Mary Powell · Traded Jan 6
$156K
LWLG Lightwave Logic · Director Siraj El-Ahmadi · Traded Dec 31
$155K
PPTA Perpetua Resources · Director Robert Dean · Traded Jan 5–6
$152K
BFLY Butterfly Network · CTO Victor Ku · Traded Jan 5
$137K
RUN Sunrun · CFO Danny Abajian · Traded Jan 6
$128K
TECTP Tectonic Financial · CEO A Sherman · Traded Jan 5
$114K
NTLA Intellia Therapeutics · EVP David Lebwohl · Traded Jan 5
$110K
RUN Sunrun · Pres. & Chief Revenue Officer Paul Dickson · Traded Jan 6
$109K
NTLA Intellia Therapeutics · EVP James Basta · Traded Jan 5
$95.8K
ABOS Acumen Pharmaceuticals · CEO Daniel OConnell · Traded Jan 5–7
$94.3K
TRAK ReposiTrak · CEO Randall Fields · Traded Jan 5–6
$90.7K
NTLA Intellia Therapeutics · EVP Eliana Clark · Traded Jan 5
$87.6K
SNCY Sun Country Airlines · CEO Jude Bricker · Traded Jan 6
$82.5K
RUN Sunrun · Chief Legal & People Officer Jeanna Steele · Traded Jan 6
$78.9K
NTLA Intellia Therapeutics · EVP Birgit Schultes · Traded Jan 5
$78.4K
KEQU Kewaunee Scientific · CFO Donald Gardner · Traded Jan 6
$75.1K
CPT Camden Property Trust · EVP - COO Laurie Baker · Traded Jan 5–6
$74.8K
MOBX Mobix Labs · President Keyvan Samini · Traded Jan 5
$67.7K
NTLA Intellia Therapeutics · EVP Edward Dulac · Traded Jan 5
$58.8K
GSAT Globalstar · CEO Paul Jacobs · Traded Jan 7
$55.6K
ABOS Acumen Pharmaceuticals · Chief Legal Officer & Corp Sec Derek Meisner · Traded Jan 5–7
$52.7K
SNCY Sun Country Airlines · SVP Stephen Coley · Traded Jan 6
$31K
ABOS Acumen Pharmaceuticals · CFO & Chief Business Officer Matt Zuga · Traded Jan 5–7
$29.5K
BCV Bancroft Fund · Director Mario Gabelli · Traded Jan 5
$28.9K
NTLA Intellia Therapeutics · VP Michael Dube · Traded Jan 5
$27.5K
SNCY Sun Country Airlines · SVP Erin Neale · Traded Jan 6
$27K
ANTX AN2 Therapeutics · Officer Joshua Eizen · Traded Jan 5–6
$24.9K
SNCY Sun Country Airlines · SVP Colton Snow · Traded Jan 6
$23.6K
RUN Sunrun · Chief Accounting Officer Maria Barak · Traded Jan 6
$21.4K
ABOS Acumen Pharmaceuticals · Chief Medical Officer Eric Siemers · Traded Jan 5–6
$21.3K
MOVE Movano · CEO John Mastrototaro · Traded Jan 5
$20.6K
ABOS Acumen Pharmaceuticals · COO Russell Barton · Traded Jan 5–7
$18.4K
EKSO Ekso Bionics · COO Jason Jones · Traded Jan 6
$12.2K
CPT Camden Property Trust · Director Javier Benito · Traded Jan 5
$11.1K
ANTX AN2 Therapeutics · Chief Development Officer Sanjay Chanda · Traded Jan 5–6
$9.31K
ANTX AN2 Therapeutics · CFO Lucy Day · Traded Jan 5–6
$8.86K
SERV Serve Robotics · General Counsel Evan Dunn · Traded Jan 6
$7.66K
ANTX AN2 Therapeutics · Chief Strategy Officer Stephen Prior · Traded Jan 5–6
$6.49K
ZSPC zSpace · CEO Paul Kellenberger · Traded Jan 6
$6.48K
SNCY Sun Country Airlines · Chief Acct. Off. & VP Christopher Mangione · Traded Jan 6
$4.65K
ALXO Alx Oncology · SVP Shelly Pinto · Traded Jan 6
$4.36K
ZSPC zSpace · CFO Erick DeOliveira · Traded Jan 6
$4.08K
ASTI Ascent Solar Technologies · Director Reynolds Forrest · Traded Dec 30
$2.41K
ZSPC zSpace · Officer Michael Harper · Traded Jan 6
$2.37K

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist